Fluvoxamine: all 49 studies that test it
Page 1 of 1. Open to participants first (3), then studies with results posted, then the rest; newest registration first within each.
- sElective Serotonin reuPtake inhibitoRs In posT-covid After COVID-19RecruitingNCT07359482Phase 3
- Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac SurgeryRecruitingNCT06969287Phase 3
- Pragmatic Trial of Obsessive-compulsive DisorderRecruitingNCT04539951Phase 2
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)CompletedNCT05894564Phase 3Results posted
- ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)CompletedNCT05890586Phase 3Results posted
- Fluvoxamine for Long COVID-19CompletedNCT05874037Phase 2/3Results posted
- ACTIV-6: COVID-19 Study of Repurposed MedicationsCompletedNCT04885530Phase 3Results posted
- Fluvoxamine for Early Treatment of Covid-19 (Stop Covid 2)CompletedNCT04668950Phase 3Results posted
- COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)CompletedNCT04510194Phase 3Results posted
- A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 InfectionCompletedNCT04342663Phase 2Results posted
- A Policy Relevant US Trauma Care System Pragmatic Trial for PTSD and ComorbidityCompletedNCT02655354Not applicableResults posted
- A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive DisorderCompletedNCT01933919Phase 3Results posted
- To Determine the Effect of KP-001 on Rosuvastatin, Caffeine PK and the Effect of Fluvoxamine on KP-001 PK in VolunteersCompletedNCT06821698Phase 1
- Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy SubjectsCompletedNCT06232109Phase 1
- A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male SubjectsCompletedNCT05888207Phase 1
- A Drug-Drug Interaction Study to Assess the CYP1A2 and CYP3A4 Interaction Potential of TEV-56286 (anle138b)CompletedNCT05532358Phase 1
- Risk of CYP2C19 Phenoconversion in Healthy Volunteers With Rapid, Normal, and Intermediate Predicted Metabolizers' StatusStatus unknownNCT05264142Phase 1
- Fluvoxamine to Augment Olfactory Recovery For Long COVID-19 ParosmiaWithdrawnNCT05216614Phase 2
- Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464CompletedNCT05121714Phase 1
- Randomized-controlled Trial of the Effectiveness of COVID-19 Early Treatment in CommunityCompletedNCT05087381Phase 4
- Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive DisorderStatus unknownNCT04963257Phase 4
- Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected PatientsCompletedNCT04718480Phase 2
- Fluvoxamine for Adults With Mild to Moderate COVID-19SuspendedNCT04711863Phase 2
- A Study to Assess the Effect of Fluvoxamine and Smoking on Pharmacokinetics ( the Movement of Drugs Within the Body) of AZD4635 in Healthy VolunteersCompletedNCT04478513Phase 1
- A Clinical Trial of Fluvoxamine for MelancholiaStatus unknownNCT04160377Phase 2
- Study to Characterize the Effects of Cytochrome p450 1A2 Inhibition on Systemic Exposure to BMS-986165CompletedNCT03930602Phase 1
- Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.CompletedNCT03634345Phase 1
- Drug-Drug Interaction (DDI) Study for TD-9855CompletedNCT03432793Phase 1
- Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological CharacteristicsStatus unknownNCT03219008Phase 4
- The Study of the Pathogenesis and Cognitive Behavioral Group Therapy in Obsessive-Compulsive DisorderCompletedNCT02739061Not applicable
- The Effect of Fluvoxamine on Polysonogram in Depressed Patients With InsomniaStatus unknownNCT02442713Not applicable
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Methylphenidate Hydrochloride Controlled-Release Tablets Augmentation Strategy for Patients With Obsessive Compulsive DisorderCompletedNCT02194075Phase 4
- Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD PatientsCompletedNCT02022709Phase 4
- Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With FluvoxamineCompletedNCT02016261Phase 4
- Study to Evaluate the Effect of Multiple-dose of Fluvoxamine on the Plasma Concentration of Quetiapine (FK949E) in Healthy Male VolunteersCompletedNCT01908296Phase 1
- Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia PatientsStatus unknownNCT01832285Not applicable
- Kinetics of Fluvoxamine and Digoxin in Subjects With Different MDR1 GenotypesCompletedNCT01704638Phase 1
- Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors.CompletedNCT01700270Phase 1
- A Study of the Effect of Fluvoxamine on the Pharmacokinetics of RO4917523 in Healthy VolunteersCompletedNCT01665404Phase 1
- Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, FluvoxamineCompletedNCT01540500Phase 1
- Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and FluvoxamineCompletedNCT01401491Phase 4
- Impact of Citalopharm and Fluvoxamine on Platelet Response to ClopidogrelCompletedNCT01396720Phase 1
- Fluvoxamine and Sertraline in Childhood Autism - Does SSRI Therapy Improve Behaviour and/or Mood?CompletedNCT00655174Phase 3
- Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive FunctionStatus unknownNCT00645580Not applicable
- Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and AdolescentsCompletedNCT00353028Phase 4
- Fluvoxamine Maleate in the Treatment of Obsessive-Compulsive Disorder: A Post-marketing Clinical Study in Children and AdolescentsTerminatedNCT00352768Phase 4
- Interaction Between Fluvoxamine and SildenafilCompletedNCT00175981Phase 1
- Treatment for Anxiety in ChildrenCompletedNCT00000389Phase 3